COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS

Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban, an oral inhibitor of Xa factor, nowadays can be considered as a drug with very good safety profile according to randomized trials results and performed indirect comparisons.

Detalhes bibliográficos

Principais autores:	V. A. Sulimov, D. A. Napalkov, A. A. Sokolova
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Столичная издательская компания 2015-09-01
coleção:	Рациональная фармакотерапия в кардиологии
Assuntos:	фибрилляция предсердий профилактика инсульта геморрагические осложнения апиксабан дабигатран ривароксабан
Acesso em linha:	http://www.rpcardio.ru/jour/article/view/109
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!